Literature DB >> 6986442

Stunted growth Candida albicans in human amniotic fluid in vitro.

P Auger, G Marquis, L Dallaire, J Joly.   

Abstract

The interaction of human AF with the pathogenic yeast Candida albicans was studied in vitro in 262 samples from early midtrimester and term gestations. Among 111 fluids collected between 15 and 18 weeks, 84% (93) manifested growth-inhibiting activity on 10(2) fungal cells/ml at 24 hr. This phenomenon persisted to a similar extent in late pregnancy. It could not be explained by a lack of nutrients in AF, since the addition of TSB failed to influence the proportion of active fluids. Depletion of the yeast cell glycogen reserve potentiated the degree of fungistasis achieved in several samples (p = 0.0009). Supplementation with either SDB or a physiologic concentration of carbon dioxide effected a complete reversal (p less than 0.0001). Preliminary data as well as overall results suggest that the absolute transferrin content and its pH-dependent saturation with iron are key factors invovled in the growth-inhibiting activity. Germ tube formation was unrestricted in 115 second trimester fluids studied. Human AF probably helps to prevent congenital candidiasis, and this protective function must be better defined.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6986442

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  2 in total

1.  Total hemoglobin concentration in amniotic fluid is increased in intraamniotic infection/inflammation.

Authors:  Edi Vaisbuch; Roberto Romero; Offer Erez; Juan Pedro Kusanovic; Francesca Gotsch; Nandor G Than; Shali Mazaki-Tovi; Pooja Mittal; Sam Edwin; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2008-10       Impact factor: 8.661

2.  Bacterial growth in amniotic fluid is dependent on the iron-availability and the activity of bacterial iron-uptake system.

Authors:  Young-Joon Ahn; Sang-Kee Park; Jae-Wook Oh; Hui Yu Sun; Sung-Heui Shin
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.